We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+10.93%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$3.18B
AUM Growth
-$2.44B
Cap. Flow
-$2.64B
Cap. Flow %
-83.08%
Top 10 Hldgs %
60.78%
Holding
672
New
112
Increased
61
Reduced
251
Closed
169

Sector Composition

Rank Sector Weight
1 Energy 29.51%
2 Technology 21.97%
3 Healthcare 10.49%
4 Real Estate 7.26%
5 Industrials 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOCU
151
DocuSign
DOCU
$10.9B
$2.08M 0.07%
+35,000
New +$1.61M
SNDX icon
152
Syndax Pharmaceuticals
SNDX
$1.76B
$2.07M 0.07%
+95,949
New +$1.47M
FUSN
153
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$2.05M 0.06%
213,107
-61,461
-22% -$299K
BZAI
154
Blaize Holdings
BZAI
$138M
$2.02M 0.06%
187,581
-84,314
-31% -$897K
ODFL icon
155
Old Dominion Freight Line
ODFL
$43.8B
$1.99M 0.06%
+9,800
New +$1.94M
SLAM
156
DELISTED
Slam Corp. Class A Ordinary Share
SLAM
$1.98M 0.06%
182,628
-82,344
-31% -$893K
PLD icon
157
Prologis
PLD
$132B
$1.98M 0.06%
14,848
-37,697
-72% -$4.28M
TMCI icon
158
Treace Medical Concepts
TMCI
$284M
$1.98M 0.06%
154,913
-18,091
-10% -$183K
PODD icon
159
Insulet
PODD
$9.66B
$1.96M 0.06%
9,047
-5,353
-37% -$918K
GEHC icon
160
GE HealthCare
GEHC
$31.8B
$1.95M 0.06%
25,203
-39,132
-61% -$2.74M
VSAC
161
DELISTED
Vision Sensing Acquisition Corp. Class A Common Stock
VSAC
$1.94M 0.06%
175,381
-78,831
-31% -$872K
KRC icon
162
Kilroy Realty
KRC
$4.34B
$1.93M 0.06%
+48,336
New +$1.59M
DCPH
163
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$1.9M 0.06%
117,920
-35,817
-23% -$457K
IMCR icon
164
Immunocore
IMCR
$1.75B
$1.89M 0.06%
27,641
-11,704
-30% -$608K
ANAB icon
165
AnaptysBio
ANAB
$1.62B
$1.87M 0.06%
87,124
-37,339
-30% -$644K
LCID icon
166
PUT
Lucid Motors
LCID
$2.75B
$1.85M 0.06%
75,000
CSCO icon
167
Cisco
CSCO
$476B
$1.84M 0.06%
36,506
CDLX icon
168
Cardlytics
CDLX
$20.7M
$1.84M 0.06%
+20,000
New +$2.03M
MDT icon
169
Medtronic
MDT
$110B
$1.84M 0.06%
22,328
-37,468
-63% -$2.86M
KDK
170
Kodiak AI
KDK
$842M
$1.78M 0.06%
170,767
-76,755
-31% -$794K
LTC
171
LTC Properties
LTC
$2.13B
$1.78M 0.06%
55,297
-92,443
-63% -$2.99M
CSTA
172
DELISTED
Constellation Acquisition Corp I
CSTA
$1.78M 0.06%
160,688
-72,679
-31% -$800K
KNSA icon
173
Kiniksa Pharmaceuticals
KNSA
$5.97B
$1.77M 0.06%
100,722
-5,701
-5% -$93.7K
INSM icon
174
Insmed
INSM
$28.9B
$1.76M 0.06%
56,727
-2,565
-4% -$66.5K
PHYT
175
DELISTED
Pyrophyte Acquisition Corp.
PHYT
$1.76M 0.06%
159,438
-95,552
-37% -$1.05M

Similar funds

UBS O'Connor's Q4 2023 Portfolio in Review

As of Q4 2023, UBS O'Connor held 672 positions worth $3.18B, down 43% from $5.62B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

UBS O'Connor withdrew a net $2.64B in Q4 2023, closing 169 positions and reducing 251 holdings. Its most notable exit was Activision Blizzard, an estimated $1.06B position sold in full.

By sector, the portfolio is most concentrated in Energy at 30% of assets, up from 3.6% a quarter earlier, followed by Technology and Healthcare.

Against the trend, UBS O'Connor opened a new position in Pioneer Natural Resource Co. worth $579M.

  • UBS O'Connor's largest Q4 2023 buy was Pioneer Natural Resource Co.: 2,576,808 shares worth $579M.
  • UBS O'Connor added most to Splunk Inc in Q4 2023, an estimated $446M increase.
  • UBS O'Connor's biggest Q4 2023 reduction was Capri Holdings, cutting an estimated $36.6M.
  • UBS O'Connor fully exited Activision Blizzard in Q4 2023, selling an estimated $1.06B.
  • UBS O'Connor's ten largest holdings make up 61% of its $3.18B portfolio in Q4 2023.
  • UBS O'Connor opened 112 new positions and closed 169 in Q4 2023.
  • UBS O'Connor's portfolio value fell 43% quarter-over-quarter to $3.18B.

Based on UBS O'Connor's 13F filing for Q4 2023, filed 14 Feb 2024.